Extremely meaningful positive changes in Champions Oncology Inc (NASDAQ: CSBR) investment behavior have recently occurred: its shorter term price trend turned up, the stock’s recent price rise disrupted its longer term downtrend, positive upside/downside volume developed, and the stock rose on very heavy volume.
In light of these very positive signals we are reviewing our current Overall Rating of D. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
CSBR’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to be a major Value Builder.
Champions Oncology has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Champions Oncology has a good Appreciation Score of 76 but a very low Power Rating of 3, resulting in the Negative Value Trend Rating.
Recent Price Action
On 12/6/19, Champions Oncology Inc (NASDAQ: CSBR) stock enjoyed a very large increase of 7.4%, closing at $7.85. Moreover, trading volume in this advance was exceptionally high at 368% of normal. The stock has risen 42.5% during the last week but has been extremely weak relative to the market over the last nine months.